Answers are grounded in this paper and cite their sources.
BACKGROUND AND AIMS: Phenolic compounds in extra-virgin olive oil (EVOO) may improve oxidative status, yet responses may vary across populations and dietary contexts. This study was aimed to evaluate whether long-term consumption of a tyrosol/hydroxytyrosol-enriched EVOO (HP-EVOO) improves plasma total antioxidant capacity (TEAC) in older adults at high cardiovascular risk, and whether baseline adherence to a Mediterranean diet (MedDiet) modifies this response. METHODS: In this pilot randomized intervention trial, 34 older adults (73.1 ± 5.9 years; 65% men) stratified as healthy controls or post-myocardial infarction (post-MI) consumed 25 mL/day of standard EVOO, HP-EVOO, or refined olive oil (ROO) for 26 weeks. Plasma TEAC was measured at baseline and follow-up. Baseline MedDiet adherence was derived from 3-day food diaries and categorized as low vs high. RESULTS: TEAC changes differed by clinical status within the EVOO group: post-MI participants showed a greater increase than healthy controls (+402 μM; 95% CI 162-641). Similarly, within the EVOO group, participants with high vs low MedDiet adherence exhibited a greater TEAC increase (+274 μM; 95% CI 1.6-545). No significant between-group TEAC differences were observed after HP-EVOO or ROO. CONCLUSION: In older adults, standard EVOO with moderate phenolic content improved plasma TEAC in post-MI participants and in those with higher baseline MedDiet adherence, whereas further phenolic enrichment did not enhance TEAC. These findings suggest that antioxidant responses to olive oil are context-dependent and not solely driven by phenolic concentration. Larger trials are warranted.
No takes yet. Share an insight, caveat, or question.
Sidibé et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: